Speaker: Christopher H. van Dyck, MD
Professor of Psychiatry, Neurology, and Neuroscience
Director, Alzheimer’s Disease Research Unit
Director, Alzheimer’s Disease Research Center
Director, Division of Aging and Geriatric Psychiatry
Yale School of Medicine
Title: “Lecanemab: The first disease-modifying therapy for Alzheimer’s disease”
Date: Tuesday, December 5, 2023
Time: 12n-1pm EST
Location: Virtual –see link below
Join Zoom Meeting
https://uconn-edu.zoom.us/j/91452383057?pwd=d0NRNmlMWTBmYVljRkhyeDk2QW1IUT09
Meeting ID: 914 5238 3057
Passcode: 984843
---
One tap mobile
+13052241968,,91452383057#,,,,*984843# US
+13092053325,,91452383057#,,,,*984843# US
---
Dial by your location
• +1 305 224 1968 US
• +1 309 205 3325 US
• +1 312 626 6799 US (Chicago)
• +1 646 931 3860 US
• +1 929 205 6099 US (New York)
• +1 301 715 8592 US (Washington DC)
• +1 689 278 1000 US
• +1 719 359 4580 US
• +1 253 205 0468 US
• +1 253 215 8782 US (Tacoma)
• +1 346 248 7799 US (Houston)
• +1 360 209 5623 US
• +1 386 347 5053 US
• +1 507 473 4847 US
• +1 564 217 2000 US
• +1 669 444 9171 US
• +1 669 900 6833 US (San Jose)
Meeting ID: 914 5238 3057
Passcode: 984843
Find your local number: https://uconn-edu.zoom.us/u/af0MFU4Ab
For more information, contact: Robin Addison at addison@uchc.edu